Generic Drugmakers Can Export Bayer Drug Ingredients

March 9, 2017

An Indian court ruled in favor of two drugmakers to export the main ingredients of two of Bayer AG’s blockbuster drugs to develop generics in other countries, according to a Bloomberg article.

The Indian companies, Natco Pharma Ltd. and Alembic Pharmaceuticals Ltd., can now export sorafenib, the active ingredient in Bayer’s cancer drug Nexavar; and rivaroxaban, used to make its blockbuster blood thinner Xarelto, for research purposes, the story said.

Merck's suit attempted to stop the exports of the active ingredients needed to make test batches of its patented products.

Read the Bloomberg story